1006 related articles for article (PubMed ID: 24507858)
21. Concentrated intravitreal amphotericin B in fungal endophthalmitis.
Payne JF; Keenum DG; Sternberg P; Thliveris A; Kala A; Olsen TW
Arch Ophthalmol; 2010 Dec; 128(12):1546-50. PubMed ID: 21149777
[TBL] [Abstract][Full Text] [Related]
22. Exogenous fungal endophthalmitis: microbiology and clinical outcomes.
Wykoff CC; Flynn HW; Miller D; Scott IU; Alfonso EC
Ophthalmology; 2008 Sep; 115(9):1501-7, 1507.e1-2. PubMed ID: 18486220
[TBL] [Abstract][Full Text] [Related]
23. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
Bucher RS; Hall E; Reed DM; Richards JE; Johnson MW; Zacks DN
Arch Ophthalmol; 2005 May; 123(5):649-53. PubMed ID: 15883284
[TBL] [Abstract][Full Text] [Related]
24. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes.
Busbee BG; Recchia FM; Kaiser R; Nagra P; Rosenblatt B; Pearlman RB
Ophthalmology; 2004 Aug; 111(8):1495-503; discussion 1503. PubMed ID: 15288977
[TBL] [Abstract][Full Text] [Related]
25. Management of postoperative Acremonium endophthalmitis.
Weissgold DJ; Maguire AM; Brucker AJ
Ophthalmology; 1996 May; 103(5):749-56. PubMed ID: 8637683
[TBL] [Abstract][Full Text] [Related]
26. Vitrectomy for endogenous fungal endophthalmitis.
Shen X; Xu G
Ocul Immunol Inflamm; 2009; 17(3):148-52. PubMed ID: 19585356
[TBL] [Abstract][Full Text] [Related]
27. An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery.
Cakir M; Imamoğlu S; Cekiç O; Bozkurt E; Alagöz N; Oksüz L; Yilmaz OF
Curr Eye Res; 2009 Nov; 34(11):988-95. PubMed ID: 19958115
[TBL] [Abstract][Full Text] [Related]
28. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
Yamashita T; Uemura A; Kita H; Sakamoto T
J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
[TBL] [Abstract][Full Text] [Related]
29. Acute endophthalmitis following intravitreal triamcinolone acetonide injection.
Moshfeghi DM; Kaiser PK; Scott IU; Sears JE; Benz M; Sinesterra JP; Kaiser RS; Bakri SJ; Maturi RK; Belmont J; Beer PM; Murray TG; Quiroz-Mercado H; Mieler WF
Am J Ophthalmol; 2003 Nov; 136(5):791-6. PubMed ID: 14597028
[TBL] [Abstract][Full Text] [Related]
30. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.
Chaudhary KM; Romero JM; Ezon I; Fastenberg DM; Deramo VA
Retina; 2013; 33(7):1407-16. PubMed ID: 23492945
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and Outcomes of Endogenous Endophthalmitis: Eight-Year Experience at a Tertiary Care Center.
Modjtahedi BS; Finn AP; Barb SM; MacLachlan MJ; van Zyl T; Papakostas TD; Eliott D
Ophthalmol Retina; 2019 Jan; 3(1):61-72. PubMed ID: 30929817
[TBL] [Abstract][Full Text] [Related]
33. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
[TBL] [Abstract][Full Text] [Related]
34. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
Sen P; Gopal L; Sen PR
Retina; 2006 Oct; 26(8):935-9. PubMed ID: 17031296
[TBL] [Abstract][Full Text] [Related]
35. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
37. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
40. Incidence of endophthalmitis after 23-gauge pars plana vitrectomy.
Lin Z; Feng X; Zheng L; Moonasar N; Shen L; Wu R; Chen F
BMC Ophthalmol; 2018 Jan; 18(1):16. PubMed ID: 29361927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
